Argus Investors Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,579
| Closed | -$308K | – | 119 |
|
|
2024
Q4 | $308K | Buy |
3,579
+475
| +15% | +$40.9K | 0.21% | 108 |
|
|
2024
Q3 | $370K | Buy |
3,104
+114
| +4% | +$13.6K | 0.24% | 99 |
|
|
2024
Q2 | $427K | Buy |
2,990
+1,405
| +89% | +$201K | 0.26% | 94 |
|
|
2024
Q1 | $204K | Buy |
+1,585
| New | +$204K | 0.12% | 108 |
|